Literature DB >> 8953597

NCCN Non-Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.

D S Ettinger1, J D Cox, R J Ginsberg, R Komaki, M G Kris, R B Livingston, D J Sugarbaker.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8953597

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  10 in total

1.  Determinants of practice patterns and quality gaps in lung cancer staging and diagnosis.

Authors:  David E Ost; Jiangong Niu; Linda S Elting; Thomas A Buchholz; Sharon H Giordano
Journal:  Chest       Date:  2014-05       Impact factor: 9.410

Review 2.  [Treatment of non-small cell lung cancer].

Authors:  N Reinmuth; D Heigener; M Reck
Journal:  Internist (Berl)       Date:  2011-12       Impact factor: 0.743

3.  Association of patient characteristics with chemotherapy receipt among depressed and non-depressed patients with non-small cell lung cancer.

Authors:  Donald R Sullivan; Linda Ganzini; Ariel Lopez-Chavez; Christopher G Slatore
Journal:  Psychooncology       Date:  2014-04-28       Impact factor: 3.894

Review 4.  Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection.

Authors:  Martin J Edelman; Julie Schuetz
Journal:  Curr Treat Options Oncol       Date:  2002-02

5.  Predictors of imaging surveillance for surgically treated early-stage lung cancer.

Authors:  Leah M Backhus; Farhood Farjah; Steven B Zeliadt; Thomas K Varghese; Aaron Cheng; Larry Kessler; David H Au; David R Flum
Journal:  Ann Thorac Surg       Date:  2014-10-03       Impact factor: 4.330

6.  Association of Early Palliative Care With Chemotherapy Intensity in Patients With Advanced Stage Lung Cancer: A National Cohort Study.

Authors:  Austin Lammers; Christopher G Slatore; Erik K Fromme; Kelly C Vranas; Donald R Sullivan
Journal:  J Thorac Oncol       Date:  2018-10-15       Impact factor: 15.609

Review 7.  Second- and third-line treatments in non-small cell lung cancer.

Authors:  Atul Kumar; Heather Wakelee
Journal:  Curr Treat Options Oncol       Date:  2006-01

8.  Inhibition of miR-191 contributes to radiation-resistance of two lung cancer cell lines by altering autophagy activity.

Authors:  Zhenkuan Liu; Shaoxiang Huang
Journal:  Cancer Cell Int       Date:  2015-02-04       Impact factor: 5.722

Review 9.  Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality.

Authors:  Yin Chen; Shilian Hu; Lei Wu; Xiang Fang; Weiping Xu; Gan Shen
Journal:  BMJ Open       Date:  2015-07-15       Impact factor: 2.692

10.  Adjuvant chemotherapy with sequential cytokine-induced killer (CIK) cells in stage IB non-small cell lung cancer.

Authors:  Da-Peng Li; Wei Li; Jun Feng; Kai Chen; Min Tao
Journal:  Oncol Res       Date:  2015       Impact factor: 5.574
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.